Works matching DE "ENTRESTO"

Results: 289

The association of vascular access flow with sacubitril/valsartan and left ventricular ejection fraction in hemodialysis patients with heart failure with reduced ejection fraction Open Access.

Published in:

Clinical Kidney Journal, 2025, v. 18, n. 4, p. 1, doi. 10.1093/ckj/sfaf078

By:

Chen, Fan-Yu;
Tan, Ann Charis;
Chen, Chyong-Mei;
Yang, Chih-Yu;
Lee, Kuo-Hua;
Ou, Shuo-Ming;
Tsai, Ming-Tsun;
Li, Szu-Yuan;
Lin, Tong-Jia;
Kao, Zih-Kai;
Tseng, Chin-Te;
Fu, Ya-Han;
Lin, Chih-Ching

Publication type:

Article

Updates in chronic kidney disease management: A systematic review.

Published in:

Pharmacotherapy, 2025, v. 45, n. 5, p. 291, doi. 10.1002/phar.70014

By:

Ammar, Amina;
Edwin, Stephanie B.;
Whitney, Rachel;
Lipari, Melissa;
Giuliano, Christopher

Publication type:

Article

Vericiguat versus sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction in China: a cost-utility analysis.

Published in:

Acta Cardiologica, 2025, v. 80, n. 3, p. 283, doi. 10.1080/00015385.2025.2484848

By:

Zhao, Xingyuan;
Hu, Nan;
Wang, Liying;
Xia, Zongling

Publication type:

Article

Correction to: Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα–mTORC1 signaling pathway.

Published in:

2025

By:

Hu, Feng;
Yan, Senbo;
Lin, Li;
Qiu, Xiaoxia;
Lin, Xinghe;
Wang, Weiwei

Publication type:

Correction Notice

Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure.

Published in:

Heart & Vessels, 2024, v. 39, n. 2, p. 95, doi. 10.1007/s00380-023-02311-3

By:

Nishihara, Yu;
Nishimori, Makoto;
Sawa, Takuma;
Uemura, Koya;
Nagai, Shun;
Todo, Saki;
Oota, Eri;
Odajima, Susumu;
Takeuchi, Kimikazu;
Ichikawa, Yasushi;
Kintsu, Masayuki;
Yamauchi, Yuki;
Shiraki, Hiroaki;
Yamashita, Kentaro;
Fukuda, Terunobu;
Hisamatsu, Eriko;
Shimizu, Masatoshi;
Hirata, Ken-ichi;
Tanaka, Hidekazu

Publication type:

Article

The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension.

Published in:

Heart & Vessels, 2023, v. 38, n. 11, p. 1337, doi. 10.1007/s00380-023-02283-4

By:

Takigami, Yu;
Ishii, Shunsuke;
Eda, Yuko;
Yazaki, Mayu;
Fujita, Teppei;
Iida, Yuichiro;
Ikeda, Yuki;
Nabeta, Takeru;
Oikawa, Jun;
Koitabashi, Toshimi;
Ako, Junya

Publication type:

Article

Effect of sacubitril/valsartan on natriuretic peptide in patients with compensated heart failure.

Published in:

Heart & Vessels, 2023, v. 38, n. 6, p. 773, doi. 10.1007/s00380-022-02230-9

By:

Shirakabe, Akihiro;
Matsushita, Masato;
Sawatani, Tomofumi;
Noma, Satsuki;
Takayasu, Tsutomu;
Kanai, Hideki;
Asano, Miwako;
Nomura, Akiko;
Asai, Kuniya

Publication type:

Article

Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation.

Published in:

Heart & Vessels, 2020, v. 35, n. 1, p. 136, doi. 10.1007/s00380-019-01454-6

By:

Vicent, Lourdes;
Méndez-Zurita, Francisco;
Viñolas, Xavier;
Alonso-Martín, Concepción;
Arbòs, Carles Moliner;
Pamies, Julia;
Alcalde, R. Oscar;
Juárez, Miriam;
Bruña, Vanesa;
Devesa, Carolina;
Sousa-Casasnovas, Iago;
Fernández-Avilés, Francisco;
Martínez-Sellés, Manuel

Publication type:

Article

Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case report.

Published in:

European Heart Journal Case Reports, 2022, v. 6, n. 10, p. 1, doi. 10.1093/ehjcr/ytac396

By:

Bell, Elisabeth;
Desuki, Alexander;
Karbach, Susanne;
Göbel, Sebastian

Publication type:

Article

Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2024, v. 29, p. 1, doi. 10.1177/10742484241233872

By:

Lin, Ya-Wen;
Lin, Chun-Hsiang;
Lin, Cheng-Li;
Lin, Che-Huei;
Lin, Ming-Hung

Publication type:

Article

Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484221146375

By:

Matsumura, Koichiro;
Ijichi, Takeshi;
Morimoto, Junko;
Takabayashi, Kensuke;
Miho, Mitsunori;
Ueno, Keisuke;
Yagi, Eijiro;
Takase, Toru;
Ueno, Masafumi;
Nakazawa, Gaku

Publication type:

Article

Predicting Hospital Readmissions in Patients Receiving Novel-Dose Sacubitril/Valsartan Therapy: A Competing-Risk, Causal Mediation Analysis.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231219603

By:

Hou, Changchun;
Hao, Xinxin;
Sun, Ning;
Luo, Xiaolin;
Gao, Zhichun;
Chen, Ling;
Liu, Xi;
Qin, Zhexue

Publication type:

Article

Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221107799

By:

Lin, Po-Lin;
Lee, Ying-Hsiang;
Liu, Lawrence Yu-Min;
Tsai, Cheng-Ting;
Yang, Ten-Fang;
Chiou, Wei-Ru;
Hsieh, Mu-Yang;
Chang, Hung-Yu;
Huang, Chun-Che

Publication type:

Article

The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484211058681

By:

Zhang, Rui;
Sun, Xiaotong;
Li, Ya;
He, Wenzheng;
Zhu, Hongguang;
Liu, Baoshan;
Zhang, Aiyuan

Publication type:

Article

Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2021, v. 26, n. 6, p. 619, doi. 10.1177/10742484211024441

By:

Kido, Kazuhiko;
Bianco, Christopher;
Caccamo, Marco;
Fang, Wei;
Sokos, George

Publication type:

Article

PROTECTIVE EFFECTS OF ULTRASOUND-BASED PREOPERATIVE EXOGENOUS SACUBITRIL/VALSARTAN ON THE HEART AND KIDNEY OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.

Published in:

Farmacia, 2023, v. 71, n. 4, p. 834, doi. 10.31925/farmacia.2023.4.20

By:

YUNFEI WANG;
LINA SUN;
JING YU;
YE ZHENG;
YAHUAN HAO;
YANJIE SU;
LIQIU YAN

Publication type:

Article

Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction.

Published in:

Clinical Hemorheology & Microcirculation, 2021, v. 77, n. 4, p. 425, doi. 10.3233/CH-201032

By:

Li, Bao-Hua;
Fang, Kuai-Fa;
Lin, Pei-Huan;
Zhang, Yi-Hui;
Huang, Yong-Xiang;
Jie, Hai

Publication type:

Article

Effect of sacubitril/valsartan on heart rate variability parameters in patients with heart failure with reduced ejection fraction.

Published in:

2023

By:

Isailović-Keković, Mirjana;
Keković, Predrag

Publication type:

Abstract

Sacubitril/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38694-6

By:

Tantisuwat, Lalida;
Saengklub, Nakkawee;
Boonpala, Pakit;
Kumphune, Sarawut;
Panyasing, Yaowalak;
Kalandakanond-Thongsong, Sarinee;
Kijtawornrat, Anusak

Publication type:

Article

Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1357673

By:

Arbel, Ronen;
Azab, Abed N.;
Oberoi, Mansi;
Aboalhasan, Enis;
Star, Artyom;
Elhaj, Khaled;
Khalil, Fouad;
Alnsasra, Hilmi

Publication type:

Article

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome.

Published in:

Frontiers in Pharmacology, 2023, p. 01

By:

Shuangcui Wang;
Yuli Wang;
Yun Deng;
Jiaqi Zhang;
Xijuan Jiang;
Jianchun Yu;
Jiali Gan;
Wenyun Zeng;
Maojuan Guo

Publication type:

Article

Research progress of sacubitril/valsartan in heart failure patients with preserved ejection fraction.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 6, p. 471, doi. 10.5246/jcps.2022.06.041

By:

Jingjing Cao;
Shujuan Zhao;
Chenglong Zhao;
Peizhi Ma

Publication type:

Article

Effect of Guanxin-V Mixture Combined with Sacubitril Valsartan on Cardiac Function after PCI in STEMI Patients.

Published in:

Medicinal Plant, 2024, v. 15, n. 1, p. 75, doi. 10.19600/j.cnki.issn2152-3924.2024.01.019

By:

Zhiliang CHEN;
Wei ZHANG;
Jun GONG;
Feng KE;
Ning GU

Publication type:

Article

Bilanz Novartis 2023: Fürs Herz und gegen Krebs.

Published in:

Nachrichten aus der Chemie, 2024, v. 72, n. 4, p. 41, doi. 10.1002/nadc.20244140771

By:

Bulmahn, Maren

Publication type:

Article

Novartis‐Bilanz 2021: Für Herz und Nieren.

Published in:: Nachrichten aus der Chemie, 2022, v. 70, n. 4, p. 37, doi. 10.1002/nadc.20224124094
Publication type:: Article

Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.

Published in:

PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0295226

By:

Palffy, Eszter;
Lewis, David John

Publication type:

Article

Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction.

Published in:

PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291754

By:

Shen, Xiaozhu;
Gong, Chen;
Liu, Mengqian;
Jiang, Yi;
Xu, Yiwen;
Ge, Zhonglin;
Tao, Zhonghai;
Dong, Nan;
Liao, Juan;
Yu, Liqiang;
Fang, Qi

Publication type:

Article

The angiotensin receptor neprilysin inhibitor LCZ696 attenuates renal fibrosis via ASK1/JNK/p38 MAPK-mediated apoptosis in unilateral ureteral obstruction.

Published in:

PLoS ONE, 2023, v. 18, n. 6, p. 1, doi. 10.1371/journal.pone.0286903

By:

Ding, Jun;
Cui, Sheng;
Li, Song Yu;
Cui, Lin Yan;
Nan, Qi Yan;
Lin, Xue Jing;
Xuan, Mei Ying;
Jin, Jian;
Piao, Shang Guo;
Jiang, Yu Ji;
Zheng, Hai Lan;
Jin, Ji Zhe;
Chung, Byung Ha;
Yang, Chul Woo;
Cui, Jing Hao;
Li, Can

Publication type:

Article

A prospective, randomized, double‐blind, placebo‐controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.

Published in:

Journal of Veterinary Internal Medicine, 2018, v. 32, n. 5, p. 1555, doi. 10.1111/jvim.15240

By:

Newhard, Daniel K.;
Jung, Seungwoo;
Winter, Randolph L.;
Duran, Sue H.

Publication type:

Article

Sacubitril/valsartan alleviates myocardial infarction-induced inflammation in mice by promoting M2 macrophage polarisation via regulation of PI3K/Akt pathway.

Published in:

Acta Cardiologica, 2024, v. 79, n. 7, p. 768, doi. 10.1080/00015385.2024.2400401

By:

Jin, Nan;
Qiu, Ying;
Zhang, Kuanxin;
Fang, Yulin;
Qu, Shifang;
Zhu, Lu;
Li, Han;
Nie, Bin

Publication type:

Article

The effects of sacubitril/valsartan on heart failure with preserved ejection fraction: a meta-analysis.

Published in:

Acta Cardiologica, 2022, v. 77, n. 6, p. 471, doi. 10.1080/00015385.2021.1963101

By:

Yuheng, Jiao;
Yanyan, Li;
Song, Zhang;
Yafang, Zha;
Xiaowei, Meng;
Jiayan, Zhang

Publication type:

Article

Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan.

Published in:

Acta Cardiologica, 2022, v. 77, n. 5, p. 416, doi. 10.1080/00015385.2021.1950371

By:

Correale, Michele;
Mallardi, Adriana;
Tricarico, Lucia;
Mazzeo, Pietro;
Ferraretti, Armando;
Diella, Claudia;
Romano, Valentina;
Merolla, Giuseppina;
Iacoviello, Massimo;
Di Biase, Matteo;
Brunetti, Natale Daniele

Publication type:

Article

Effect of Sacubitril/Valsartan on circulating catecholamine levels during a 6-month follow-up in heart failure patients. Timeo Danaos et dona ferentes?

Published in:

Acta Cardiologica, 2021, v. 76, n. 4, p. 396, doi. 10.1080/00015385.2020.1746094

By:

Chalikias, George;
Kikas, Petros;
Thomaidis, Adina;
Rigopoulos, Panagiotis;
Pistola, Anastasia;
Lantzouraki, Asimina;
Zisimopoulos, Athanasios;
Tziakas, Dimitrios

Publication type:

Article

Determinants of maximal dose titration of sacubitril/valsartan in clinical practice.

Published in:

Acta Cardiologica, 2021, v. 76, n. 1, p. 20, doi. 10.1080/00015385.2019.1686226

By:

Martens, Pieter;
Verluyten, Lina;
Van de Broek, Heleen;
Somers, Frauke;
Dauw, Jeroen;
Dupont, Matthias;
Mullens, Wilfried

Publication type:

Article

Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test.

Published in:

Acta Cardiologica, 2020, v. 75, n. 8, p. 732, doi. 10.1080/00015385.2019.1669317

By:

Malfatto, Gabriella;
Ravaro, Silvia;
Caravita, Sergio;
Baratto, Claudia;
Sorropago, Antonio;
Giglio, Alessia;
Tomaselli, Michele;
Parati, Gianfranco;
Villani, Alessandra

Publication type:

Article

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy.

Published in:

Medicina (1010660X), 2021, v. 57, n. 5, p. 416, doi. 10.3390/medicina57050416

By:

Kim, Hyue-Mee;
Kim, Kyung-Hee;
Park, Jin-Sik;
Oh, Byung-Hee

Publication type:

Article

Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study.

Published in:

Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02051-x

By:

Li, Manzhi;
Zhong, Ao;
Tang, Yifan;
Yu, Jinnuo;
Wu, Mengmeng;
Selvam, Karthick Kumaran Munisamy;
Sun, Dong

Publication type:

Article

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0

By:

Lee, Wei-Chieh;
Liao, Ting-Wei;
Chen, Tien-Yu;
Fang, Hsiu-Yu;
Fang, Yen-Nan;
Chen, Huang-Chung;
Lin, Yu-Sheng;
Chang, Shang-Hung;
Chen, Mien-Cheng

Publication type:

Article

Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.

Published in:

Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 549, doi. 10.1007/s10557-022-07315-1

By:

Wang, Qiqi;
Zhuo, Chengui;
Xia, Qi;
Jiang, Jiajia;
Wu, Bifeng;
Zhou, Dongchen;
Shu, Zheyue;
Zhao, Jianqiang;
Chen, Miao;
Chen, Heng;
Sun, Zewei;
Zhang, Biqi;
Han, Jie;
Zheng, Liangrong

Publication type:

Article

Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.

Published in:

Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 915, doi. 10.1007/s10557-021-07210-1

By:

Kim, Yee Soo;
Brar, Simerjeet;
D'Albo, Natalie;
Dey, Amit;
Shah, Sachin;
Ganatra, Sarju;
Dani, Sourbha S.

Publication type:

Article

Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 5, p. 1067, doi. 10.1007/s10557-020-07099-2

By:

Aimo, Alberto;
Pateras, Konstantinos;
Stamatelopoulos, Kimon;
Bayes-Genis, Antoni;
Lombardi, Carlo Mario;
Passino, Claudio;
Emdin, Michele;
Georgiopoulos, Georgios

Publication type:

Article

Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy.

Published in:

Cardiovascular Drugs & Therapy, 2020, v. 34, n. 6, p. 755, doi. 10.1007/s10557-020-07036-3

By:

Ioannou, Adam;
Metaxa, Sofia;
Simon, Steny;
Mandal, Amit K. J.;
Missouris, Constantinos G.

Publication type:

Article

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.

Published in:

Molecules, 2021, v. 26, n. 16, p. 5006, doi. 10.3390/molecules26165006

By:

Raj, Pema;
Sayfee, Karen;
Parikh, Mihir;
Yu, Liping;
Wigle, Jeffrey;
Netticadan, Thomas;
Zieroth, Shelley

Publication type:

Article

Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1780, doi. 10.1093/ndt/gfad066

By:

Judge, Parminder K;
Herrington, William G;
Haynes, Richard

Publication type:

Article

Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1880, doi. 10.1093/ndt/gfad038

By:

He, Yi;
Jin, Ying;
Xue, Hen;
Liu, Runhan;
Zhang, Mengyu;
Liao, Ruoxi;
Chen, Maoli;
Zhou, Xueli;
He, Xueqin;
Qin, Min;
Li, Kuo;
Zou, Huiqun;
Gan, Ying;
Wang, Zhenlei;
Zheng, Li;
Zhong, Hui;
Fu, Ping

Publication type:

Article

Protective effect of sacubitril/valsartan (Entresto) on kidney function and filtration barrier injury in a porcine model of partial nephrectomy.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 80, doi. 10.1093/ndt/gfac200

By:

Brignone, Juan;
Jensen, Mia;
Jensen, Boye L;
Assersen, Kasper Bostlund;
Goetze, Jens P;
Jødal, Lars;
Andersen, Trine Borup;
Magnusdottir, Sigriður Olga;
Kloster, Brian;
Jønler, Morten;
Lund, Lars

Publication type:

Article

Renal events in patients receiving neprilysin inhibitors: a systematic review and meta-analysis.

Published in:

Nephrology Dialysis Transplantation, 2022, v. 37, n. 12, p. 2418, doi. 10.1093/ndt/gfac001

By:

Barbosa, Clara Vollmer;
Lang, Hannah;
Melk, Anette;
Schmidt, Bernhard M W

Publication type:

Article

Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report.

Published in:

European Heart Journal Case Reports, 2022, v. 6, n. 3, p. 1, doi. 10.1093/ehjcr/ytac091

By:

Siew, Kelvin Shenq Woei;
Hafidz, Muhammad Imran Abdul;
Zaidan, Fatimah Zahrah Binti Mohd;
Hadi, Mohd Firdaus bin

Publication type:

Article

Who 'nose', is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan.

Published in:

European Heart Journal Case Reports, 2021, v. 5, n. 12, p. 1, doi. 10.1093/ehjcr/ytab506

By:

Gan, Jaclyn;
Rheault, Haunnah;
Wong, Yee Weng

Publication type:

Article

Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.

Published in:

Biomedicines, 2024, v. 12, n. 4, p. 733, doi. 10.3390/biomedicines12040733

By:

Stanko, Peter;
Repova, Kristina;
Baka, Tomas;
Krajcirovicova, Kristina;
Aziriova, Silvia;
Barta, Andrej;
Zorad, Stefan;
Adamcova, Michaela;
Simko, Fedor

Publication type:

Article